134 related articles for article (PubMed ID: 34176787)
1. Therapeutic targets and molecular mechanism of calycosin for the treatment of cerebral ischemia/reperfusion injury.
Yu S; Wu K; Liang Y; Zhang H; Guo C; Yang B
Aging (Albany NY); 2021 Jun; 13(12):16804-16815. PubMed ID: 34176787
[TBL] [Abstract][Full Text] [Related]
2. An Integrated Analysis of Network Pharmacology and Experimental Validation to Reveal the Mechanism of Chinese Medicine Formula Naotaifang in Treating Cerebral Ischemia-Reperfusion Injury.
Yang T; Chen X; Mei Z; Liu X; Feng Z; Liao J; Deng Y; Ge J
Drug Des Devel Ther; 2021; 15():3783-3808. PubMed ID: 34522084
[TBL] [Abstract][Full Text] [Related]
3. A network pharmacology approach to decipher the total flavonoid extract of Dracocephalum Moldavica L. in the treatment of cerebral ischemia- reperfusion injury.
Hu X; Mola Y; Su WL; Wang Y; Zheng RF; Xing JG
PLoS One; 2023; 18(7):e0289118. PubMed ID: 37494353
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective Mechanisms of Calycosin Against Focal Cerebral Ischemia and Reperfusion Injury in Rats.
Wang Y; Ren Q; Zhang X; Lu H; Chen J
Cell Physiol Biochem; 2018; 45(2):537-546. PubMed ID: 29402799
[TBL] [Abstract][Full Text] [Related]
5. Differentially expressed genes induced by β-caryophyllene in a rat model of cerebral ischemia-reperfusion injury.
Liu S; Liu J; Wang Y; Deng L; Chen S; Wang X; Zuo T; Hu Q; Rao J; Wang Q; Dong Z
Life Sci; 2021 May; 273():119293. PubMed ID: 33705733
[TBL] [Abstract][Full Text] [Related]
6. Elucidation of the mechanism of Yiqi Tongluo Granule against cerebral ischemia/reperfusion injury based on a combined strategy of network pharmacology, multi-omics and molecular biology.
Yuan Y; Sheng P; Ma B; Xue B; Shen M; Zhang L; Li D; Hou J; Ren J; Liu J; Yan BC; Jiang Y
Phytomedicine; 2023 Sep; 118():154934. PubMed ID: 37393828
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological targets and mechanisms of calycosin against meningitis.
Nong Y; Liang Y; Liang X; Li Y; Yang B
Aging (Albany NY); 2020 Oct; 12(19):19468-19492. PubMed ID: 33031061
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics and
Xu H; Qin J; Qin L; Guo C; Yang B
Front Endocrinol (Lausanne); 2022; 13():790619. PubMed ID: 35898453
[TBL] [Abstract][Full Text] [Related]
9. Downregulated RASD1 and upregulated miR-375 are involved in protective effects of calycosin on cerebral ischemia/reperfusion rats.
Wang Y; Dong X; Li Z; Wang W; Tian J; Chen J
J Neurol Sci; 2014 Apr; 339(1-2):144-8. PubMed ID: 24548484
[TBL] [Abstract][Full Text] [Related]
10. Anti-neoplastic characteristics and potential targets of calycosin against bisphenol A-related osteosarcoma: bioinformatics analysis.
Pan Q; Wu K; Tan J; Li Y; Liang X; Su M
Bioengineered; 2021 Dec; 12(1):4278-4288. PubMed ID: 34311656
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatic and biochemical findings disclosed anti-hepatic steatosis mechanism of calycosin.
Cheng X; Liu N; Liu H; Huang N; Sun X; Zhang G
Bioorg Chem; 2020 Jul; 100():103914. PubMed ID: 32417523
[TBL] [Abstract][Full Text] [Related]
12. Calycosin Preserves BDNF/TrkB Signaling and Reduces Post-Stroke Neurological Injury after Cerebral Ischemia by Reducing Accumulation of Hypertrophic and TNF-α-Containing Microglia in Rats.
Hsu CC; Kuo TW; Liu WP; Chang CP; Lin HJ
J Neuroimmune Pharmacol; 2020 Jun; 15(2):326-339. PubMed ID: 31927682
[TBL] [Abstract][Full Text] [Related]
13. Asiaticoside Alleviates Cerebral Ischemia-Reperfusion Injury via NOD2/Mitogen-Activated Protein Kinase (MAPK)/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
Zhang C; Chen S; Zhang Z; Xu H; Zhang W; Xu D; Lin B; Mei Y
Med Sci Monit; 2020 Feb; 26():e920325. PubMed ID: 32006420
[TBL] [Abstract][Full Text] [Related]
14. Nose to brain drug delivery - A promising strategy for active components from herbal medicine for treating cerebral ischemia reperfusion.
Long Y; Yang Q; Xiang Y; Zhang Y; Wan J; Liu S; Li N; Peng W
Pharmacol Res; 2020 Sep; 159():104795. PubMed ID: 32278035
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of calycosin on cerebral ischemia and reperfusion injury in rats.
Guo C; Tong L; Xi M; Yang H; Dong H; Wen A
J Ethnopharmacol; 2012 Dec; 144(3):768-74. PubMed ID: 23123262
[TBL] [Abstract][Full Text] [Related]
16. Trilobatin promotes angiogenesis after cerebral ischemia-reperfusion injury via SIRT7/VEGFA signaling pathway in rats.
Huang F; Luo L; Wu Y; Xia D; Xu F; Gao J; Shi J; Gong Q
Phytother Res; 2022 Jul; 36(7):2940-2951. PubMed ID: 35537702
[TBL] [Abstract][Full Text] [Related]
17. Integrative findings indicate anti-tumor biotargets and molecular mechanisms of calycosin against osteosarcoma.
Tan J; Qin X; Liu B; Mo H; Wu Z; Yuan Z
Biomed Pharmacother; 2020 Jun; 126():110096. PubMed ID: 32179199
[TBL] [Abstract][Full Text] [Related]
18. Identification of differentially expressed miRNA 48 h after cerebral ischemia-reperfusion injury in mice by the technique of miRNA microarray.
Zhang Y; Ding N; Yi H; Zhao Y; Ye Z; Shen L; Li Z; Zhu Y
Can J Physiol Pharmacol; 2020 Dec; 98(12):855-860. PubMed ID: 32516555
[TBL] [Abstract][Full Text] [Related]
19. Chemical characterization of polysaccharides isolated from scrophularia ningpoensis and its protective effect on the cerebral ischemia/reperfusin injury in rat model.
Ma S; Liu X; Cheng B; Jia Z; Hua H; Xin Y
Int J Biol Macromol; 2019 Oct; 139():955-966. PubMed ID: 31400420
[TBL] [Abstract][Full Text] [Related]
20. Piceatannol protects against cerebral ischemia/reperfusion‑induced apoptosis and oxidative stress via the Sirt1/FoxO1 signaling pathway.
Wang KJ; Zhang WQ; Liu JJ; Cui Y; Cui JZ
Mol Med Rep; 2020 Dec; 22(6):5399-5411. PubMed ID: 33173979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
